Protecting Kids from Pneumonia Frederick MD

The current recommended dose schedule for 7-valent pneumococcal conjugate vaccine (PCV-7) consists of three primary doses before the age of 6 months, followed by a booster vaccination in the second year of life (3 + 1-dose schedule) in Frederick.

Dr. Amy Meiyee Cheung
(650) 497-0178
9107 Charterhouse Rd
Frederick, MD
Specialty
Pediatrics

Amy Meiyee Cheung, MD
(650) 497-0178
9107 Charterhouse Rd
Frederick, MD
Specialties
Pediatrics
Gender
Female
Education
Medical School: Mt Sinai Sch Of Med Of The City Univ Of Ny, New York Ny 10029
Graduation Year: 1999

Data Provided by:
McLaughlin Randie R Ms Practitioner
(301) 663-4774
900 Toll House Avenue
Frederick, MD
 
Hunt Sean E
(301) 695-6800
310 West 9th Street
Frederick, MD
 
Pierce Martha J MD
(301) 662-8119
300 West 9th Street
Frederick, MD
 
Jacqueline Rochelle Douge, MD, FAAP
(301) 662-3078
5846 Little Spring Ct
Frederick, MD
Specialties
Pediatrics
Gender
Male
Education
Graduation Year: 1997

Data Provided by:
Frederick Gastroenterology Associates
(301) 695-6800
310 West 9th Street
Frederick, MD
 
Isabella Blanche Bourne, MD, FAAP
(301) 663-1049
7055 Basswood Rd
Frederick, MD
Specialties
Pediatrics
Gender
Male
Education
Graduation Year: 1941

Data Provided by:
Frederick Memorial Hospital - Oncology Care Consul
(301) 662-8477
400 West 7th Street
Frederick, MD
 
Moorman Cynthia J MD
(301) 663-4774
900 Toll House Avenue
Frederick, MD
 
Data Provided by:

Protecting Kids from Pneumonia

Provided By:

Parents and babies alike will be relieved by new findings that show a reduced-dose schedule for the pneumococcal vaccine can protect infants against pneumonia and other infections.

The current recommended dose schedule for 7-valent pneumococcal conjugate vaccine (PCV-7) consists of three primary doses before the age of 6 months, followed by a booster vaccination in the second year of life (3 + 1-dose schedule). But factors such as questions about the cost-effectiveness of the current PCV-7 dose schedule have led researchers to examine reduced-dose vaccine schedules, according to background information in the study.

The researchers, Dr. Elske J.M. van Gils, of the University Medical Center Utrecht in the Netherlands, and colleagues, studied 1,003 healthy infants who were randomly assigned to receive two doses of PCV-7 at 2 months and 4 months of age, or a 2 + 1-dose schedule at 2, 4 and 11 months of age, or no vaccine (control group). The children were checked after 12 months, 18 months and 24 months for pneumococcal microorganisms in the upper part of the throat behind the nose.

Compared to those in the control group, children in both vaccine groups had far lower rates of microorganisms that can cause pneumonia and other infections, according to the report in the July 8 issue of the Journal of the American Medical Association.

"In conclusion, both two-dose and 2 + 1-dose schedules of PCV-7 significantly reduce vaccine serotype pneumococcal carriage in children. This study supports future implementation of reduced-dose PCV-7 schedules," the researchers concluded.

More information

The Nemours Foundation has more about children and pneumonia.

SOURCE: Journal of the American Medical Association, news release, July 7, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com